In healthy cells and early-stage cancer cells, TGFβ ligands stimulate signalling pathways leading to the expression of genes involved in tumour suppression, inhibition of proliferation, stimulation of differentiation, induction of apoptosis or autophagy, elimination of inflammation, and suppression of angiogenesis. This evidence concerns the gene TGFB1 and neoplasm.